本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AN2 Therapeutics, Inc.

1.25
-0.0400-3.10%
盘后1.250.00000.00%16:00 EDT
成交量:7.42万
成交额:9.26万
市值:3,762.34万
市盈率:-0.73
高:1.29
开:1.29
低:1.22
收:1.29
数据加载中...
2023/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/06

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/29

重要事件披露

8-K - Current report
2022/05/10

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

重要事件披露

8-K - Current report
2022/04/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans